Article
Anti-carbamylated protein antibodies drive AEC II toward a profibrotic phenotype by interacting with carbamylated TLR5.
Rheumatology (Oxford, England) - 1 Oct 2024
Xu Wei, Huang Minghua, Dong Rongrong, Yan Suyan, An Yan, Liu Baocheng, Ma Zhenzhen, Mu Kun, Yang Qingrui
Abstract excerpt
OBJECTIVES: This study looked at the role of anti-carbamylated protein (anti-CarP) antibodies in contributing to lung fibrosis in CTD-associated interstitial lung disease (ILD) in an autoantigen-dependent manner. METHODS: ELISA was used to test serum samples, including 89 from the CTD-ILD group and 170 from the non-CTD-ILD group, for anti-CarP levels. Male C57BL/6 mice were used for the pulmonary fibrosis model...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
